Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DX1OZY
|
||||
Drug Name |
4-[(4-Chlorophenyl)methyl]-2-{1-[2-(4-{[3-(hexahydro-1H-azepin-1-yl)propyl]oxy}phenyl)ethyl]hexahydro-1H-azepin-4-yl}-1(2H)-phthalazinone
|
||||
Synonyms |
CHEMBL1765111
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C38H47ClN4O2
|
||||
Canonical SMILES |
Clc1ccc(CC2=NN(C3CCCN(CCc4ccc(OCCCN5CCCCCC5)cc4)CC3)C(=O)c6ccccc26)cc1
|
||||
InChI |
InChI=1S/C38H47ClN4O2/c39-32-16-12-31(13-17-32)29-37-35-10-3-4-11-36(35)38(44)43(40-37)33-9-7-24-42(27-21-33)26-20-30-14-18-34(19-15-30)45-28-8-25-41-22-5-1-2-6-23-41/h3-4,10-19,33H,1-2,5-9,20-29H2
|
||||
InChIKey |
BXUKKRHEMKVWOY-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Alpha-1 adrenergic receptor | Target Info | [1587926] | ||
Histamine H1 receptor | Target Info | [1587926] | |||
PANTHER Pathway | Histamine H1 receptor mediated signaling pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.